Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Within the broader context of the pharmaceutical i
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
For the first time in its chronicle, the pharmaceu
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
China has affirmed beginning period human tests for two exploratory antibodies to battle the new coronavirus that killed more than 100,000 individuals around the world, state media Xinhua provided details regarding Tuesday.
The antibodies are being created by a Beijing-based unit of Nasdaq-recorded Sinovac Biotech, and by the Wuhan Institute of Biological Products, an offshoot of state-possessed China National Pharmaceutical Group.
In March, China gave the green-light for another clinical preliminary for a coronavirus immunization competitor created by military-upheld China’s Academy of Military Medical Sciences and HK-recorded biotech firm CanSino Bio, soon after U.S. tranquilize designer Moderna said it had started human tests for their immunization with the U.S. National Institutes of Health.